SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001374680-11-000005
Filing Date
2011-02-15
Accepted
2011-02-14 18:41:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT 1 schedule13ga.htm SC 13G/A 53204
  Complete submission text file 0001374680-11-000005.txt   54916
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 5143323222
NYMOX PHARMACEUTICAL CORP (Subject) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50514 | Film No.: 11609368
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2311 CEDAR SPRINGS ROAD SUITE 100 DALLAS TX 75201
Business Address
Starcher Michael D. (Filed by) CIK: 0001450334 (see all company filings)

Type: SC 13G/A